Ophthalmology in Glendale, AZ
11 verified ophthalmology doctors in Glendale.
Ophthalmologists are physicians who provide complete eye care, including surgery for eye disease.
NPPES tenure ≠ clinical experience. "Years on NPPES" is time since the physician first registered a National Provider Identifier, not time practicing medicine. Verify current license status with the state medical board.
Dr. Amy Leverant, MD
Ophthalmology
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Steven Chen, MD
Ophthalmology
CMS Open Payments· $594.95 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$594.95
Total received
24
Transactions
4
Paying companies
Top paying companies
Among the 23,451 ophthalmology doctors we've analyzed, about 60% received any industry payment (median $348 among those who did). This doctor's total ranks around the 79th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US ophthalmology doctors.
Payments to Steven Chen do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Robert Rubenzik, MD
Ophthalmology
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Richard Golub, MD
Ophthalmology
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. George Reiss, MD
Ophthalmology
CMS Open Payments· $55,347 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$55,347
Total received
51
Transactions
10
Paying companies
Top paying companies
Among the 23,451 ophthalmology doctors we've analyzed, about 60% received any industry payment (median $348 among those who did). This doctor's total is higher than 97% of that group — among the highest recipients.
Benchmark reflects doctors we've analyzed, not all US ophthalmology doctors.
Payments to George Reiss do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Selvin Gnanakkan, MD
Ophthalmology
CMS Open Payments· $37.56 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$37.56
Total received
2
Transactions
2
Paying companies
Top paying companies
Among the 23,451 ophthalmology doctors we've analyzed, about 60% received any industry payment (median $348 among those who did). This doctor's total is on the lower end — around the 45th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US ophthalmology doctors.
Payments to Selvin Gnanakkan do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Robert Fintelmann, MD
Ophthalmology
CMS Open Payments· $922.45 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$922.45
Total received
2
Transactions
2
Paying companies
Top paying companies
Among the 23,451 ophthalmology doctors we've analyzed, about 60% received any industry payment (median $348 among those who did). This doctor's total ranks around the 84th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US ophthalmology doctors.
Payments to Robert Fintelmann do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Shamil Patel, MD
Ophthalmology
CMS Open Payments· $13,274 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$13,274
Total received
54
Transactions
14
Paying companies
Top paying companies
Among the 23,451 ophthalmology doctors we've analyzed, about 60% received any industry payment (median $348 among those who did). This doctor's total is higher than 95% of that group — among the highest recipients.
Benchmark reflects doctors we've analyzed, not all US ophthalmology doctors.
Payments to Shamil Patel do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Wendy Huang, MD
Ophthalmology
CMS Open Payments· $34,883 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$34,883
Total received
16
Transactions
5
Paying companies
Top paying companies
Among the 23,451 ophthalmology doctors we've analyzed, about 60% received any industry payment (median $348 among those who did). This doctor's total is higher than 96% of that group — among the highest recipients.
Benchmark reflects doctors we've analyzed, not all US ophthalmology doctors.
Payments to Wendy Huang do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Sara Ghobraiel, MD
Ophthalmology
CMS Open Payments· $239.39 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$239.39
Total received
7
Transactions
4
Paying companies
Top paying companies
Among the 23,451 ophthalmology doctors we've analyzed, about 60% received any industry payment (median $348 among those who did). This doctor's total ranks around the 64th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US ophthalmology doctors.
Payments to Sara Ghobraiel do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Briggs Hoyt, MD
Ophthalmology
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.